CodeMap® 

11/18/2021 2020 Part B Utilization Data Loaded
150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2022
2021

Physician Fee Schedule

2022
2021

OPPS Fee Schedule

2022-January
2021-October

ASC Fee Schedule

2022-January
2021-October

APC Codes

2022-January
2021-October

DRG Codes

2022
2021

ASP Drug Pricing Files

January 2022
October 2021


CMS Transmittals



Shipping update: 2022 CodeMap Manuals beginning shipping 1/19. All orders will be shipped by January 31.


CodeMap® Compliance Briefing: May 5, 2017


Editor's Welcome: CLIA waived nucleic acid based assays are now available for several commonly performed infectious agents including Streptococcus A, Influenza A and B, and Respiratory Syncytial Virus (RSV). These tests can be performed in point of care (POC) settings and provide highly accurate results for patients while they are seeing their physicians. Such results can be particularly useful when treating pediatric patients and can aid in determining if antibiotic treatment is warranted. Today, we will discuss how providers should code and report these procedures, and the resultant payment from Medicare. As always, please forward your questions, comments, and suggestions to us via email. 

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap┬« is a Registered Trademark of Wheaton Partners, LLC.